Treatment Patterns of Long-Acting Somatostatin Analogs for Neuroendocrine Tumors

**Background:** Long-acting somatostatin analog therapy (LA-SSA) is recommended as first-line therapy for treatment of unresectable or metastatic neuroendocrine tumors (NETs). Understanding treatment sequencing and dosing patterns of LA-SSA is essential for clinical decision-making to provide value-...

Full description

Bibliographic Details
Main Authors: Callisia N. Clarke, Paul Cockrum, Thomas J.R. Beveridge, Michelle Jerry, Donna McMorrow, Anh Thu Tran, Alexandria T. Phan
Format: Article
Language:English
Published: Columbia Data Analytics, LLC 2023-12-01
Series:Journal of Health Economics and Outcomes Research
Online Access:https://jheor.org/article/89300-treatment-patterns-of-long-acting-somatostatin-analogs-for-neuroendocrine-tumors